BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32266158)

  • 1. The Influence of Smoking and Co-morbidity on Dose Achievement in Primary or Adjuvant Radio(Chemo)Therapy in Head and Neck Squamous Cell Carcinoma (HNSCC).
    Fazel A; Quabius ES; Fabian A; Schleicher T; Kress K; Laudien M; Huber K; Herzog A; Gonzales Donate M; Hoffmann M
    Front Oncol; 2020; 10():398. PubMed ID: 32266158
    [No Abstract]   [Full Text] [Related]  

  • 2. [Smoking and co-morbidity - it's impact on dose achievement in radio(chemo)therapy for HNSCC].
    Fazel A; Quabius ES; Fabian A; Schleicher T; Kress K; Laudien M; Huber K; Herzog A; Gonzales Donate M; Hoffmann M
    Laryngorhinootologie; 2021 Oct; 100(10):799-810. PubMed ID: 34139776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alteration of smoking habit at time of first diagnosis influences survival of patients with HNSCC.
    Fazel A; Quabius ES; Gonzales-Donate M; Laudien M; Herzog A; Kress K; Schleicher T; Fabian A; Huber K; Hoffmann M
    Mol Clin Oncol; 2020 Nov; 13(5):50. PubMed ID: 32874580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of smoking habit alteration on prognosis of head and neck cancer patients].
    Fazel A; Quabius ES; Fabian A; Gonzales Donate M; Schleicher T; Kress K; Laudien M; Huber K; Hoffmann M
    Laryngorhinootologie; 2021 Aug; 100(8):634-643. PubMed ID: 34139775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of radiochemotherapy alone to surgery plus radio(chemo)therapy for non-metastatic stage III/IV squamous cell carcinoma of the head and neck: A matched-pair analysis.
    Rades D; Meyners T; Kazic N; Bajrovic A; Rudat V; Schild SE
    Strahlenther Onkol; 2011 Sep; 187(9):541-7. PubMed ID: 21858415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
    Corvò R
    Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of concurrent radio-chemotherapy for the treatment of head and neck squamous cell carcinoma in everyday clinical practice with special reference to early mortality.
    Schlumpf M; Fischer C; Naehrig D; Rochlitz C; Buess M
    BMC Cancer; 2013 Dec; 13():610. PubMed ID: 24373220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prognostic mRNA expression signature of four 16q24.3 genes in radio(chemo)therapy-treated head and neck squamous cell carcinoma (HNSCC).
    Wintergerst L; Selmansberger M; Maihoefer C; Schüttrumpf L; Walch A; Wilke C; Pitea A; Woischke C; Baumeister P; Kirchner T; Belka C; Ganswindt U; Zitzelsberger H; Unger K; Hess J
    Mol Oncol; 2018 Dec; 12(12):2085-2101. PubMed ID: 30259648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of the time interval between surgery and adjuvant radio (chemo) therapy in HPV-negative and advanced head and neck carcinoma of unknown primary (CUP).
    Balk M; Rupp R; Mantsopoulos K; Allner M; Grundtner P; Mueller SK; Traxdorf M; Eckstein M; Speer S; Semrau S; Fietkau R; Iro H; Hecht M; Gostian AO
    BMC Cancer; 2021 Nov; 21(1):1236. PubMed ID: 34794411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of comorbidity in 9388 head and neck cancer patients: a national cohort study from the DAHANCA database.
    Bøje CR; Dalton SO; Primdahl H; Kristensen CA; Andersen E; Johansen J; Andersen LJ; Overgaard J
    Radiother Oncol; 2014 Jan; 110(1):91-7. PubMed ID: 24412015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a benefit for adjuvant radio(chemo)therapy in early cervical cancer? Results from a population-based study.
    Scharl S; Becher C; Gerken M; Scharl A; Anapolski M; Ignatov A; Inwald EC; Ortmann O; Kölbl O; Klinkhammer-Schalke M; Papathemelis T
    Arch Gynecol Obstet; 2021 Sep; 304(3):759-771. PubMed ID: 33575846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amifostine in simultaneous radiochemotherapy of advanced head and neck cancer.
    Büntzel J; Glatzel M; Kuttner K; Weinaug R; Fröhlich D
    Semin Radiat Oncol; 2002 Jan; 12(1 Suppl 1):4-13. PubMed ID: 11917277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking status and symptom burden in surgical head and neck cancer patients.
    Sterba KR; Garrett-Mayer E; Carpenter MJ; Tooze JA; Hatcher JL; Sullivan C; Tetrick LA; Warren GW; Day TA; Alberg AJ; Weaver KE
    Laryngoscope; 2017 Jan; 127(1):127-133. PubMed ID: 27392821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical trial comparing radiotherapy alone versus standard radiochemotherapy in three human papilloma virus (HPV) negative and three HPV-positive head and neck squamous cell carcinoma (HNSCC) xenograft tumour models.
    Valentini C; Ebert N; Koi L; Pfeifer M; Löck S; Erdmann C; Krause M; Baumann M
    Radiother Oncol; 2023 Jun; 183():109546. PubMed ID: 36813172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cigarette smoking cessation, duration of smoking abstinence, and head and neck squamous cell carcinoma prognosis.
    Lee JJW; Kunaratnam V; Kim CJH; Pienkowski M; Hueniken K; Sahovaler A; Lam ACL; Davies JC; Brown CM; De Almeida JR; Huang SH; Waldron JN; Spreafico A; Hung RJ; Xu W; Goldstein DP; Liu G
    Cancer; 2023 Mar; 129(6):867-877. PubMed ID: 36653915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.
    Khuri FR; Lee JJ; Lippman SM; Kim ES; Cooper JS; Benner SE; Winn R; Pajak TF; Williams B; Shenouda G; Hodson I; Fu K; Shin DM; Vokes EE; Feng L; Goepfert H; Hong WK
    J Natl Cancer Inst; 2006 Apr; 98(7):441-50. PubMed ID: 16595780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck.
    Fortin A; Wang CS; Vigneault E
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1062-9. PubMed ID: 19036528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
    Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
    Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.